The WACC of Coherus BioSciences Inc (CHRS) is 8.6%.
| Range | Selected | |
| Cost of equity | 10.90% - 14.70% | 12.80% |
| Tax rate | 0.10% - 1.10% | 0.60% |
| Cost of debt | 7.00% - 7.70% | 7.35% |
| WACC | 7.9% - 9.2% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.54 | 1.76 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.90% | 14.70% |
| Tax rate | 0.10% | 1.10% |
| Debt/Equity ratio | 3.38 | 3.38 |
| Cost of debt | 7.00% | 7.70% |
| After-tax WACC | 7.9% | 9.2% |
| Selected WACC | 8.6% | |